Renal Cancer - Results from #5560

The interaction of sorafenib and regorafenib with membranes is modulated by their lipid composition September 8, 2016

Outcomes of Laparoscopic Partial Nephrectomy in Patients Continuing Aspirin Therapy September 8, 2016

An Empiric Evaluation of the Effect of Variation in Intensity of Follow-Up for Surgically Treated Renal Neoplasms on Cancer Specific Survival September 7, 2016

Association of axitinib plasma exposure and genetic polymorphisms of ABC transporters with axitinib-induced toxicities in patients with renal cell carcinoma September 6, 2016

Ultrasound-guided radiofrequency ablation for cT1a renal masses in poor surgical candidates: mid-term, single-center outcomes September 6, 2016

The impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma September 5, 2016

Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis September 5, 2016

Cancer risk and mortality after kidney transplantation: a population-based study on differences between Danish centres using standard immunosuppression with and without glucocorticoids September 5, 2016

Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival September 2, 2016

LpMab-19 Recognizes Sialylated O-Glycan on Thr76 of Human Podoplanin September 1, 2016

Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review September 1, 2016

Evaluation of Immunogenicity of Nivolumab Monotherapy and its Clinical Relevance in Patients With Metastatic Solid Tumors September 1, 2016

Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease September 1, 2016

MEK inhibition abrogates sunitinib resistance in a renal cell carcinoma patient-derived xenograft model August 31, 2016

Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel August 30, 2016

Sunitinib treatment in patients with advanced renal cell cancer: the Brazilian National Cancer Institute (INCA) experience August 30, 2016

Future perspectives in cancer immunotherapy August 30, 2016

Preoperative hydronephrosis is associated with less decline in renal function after radical nephroureterectomy for upper tract urothelial carcinoma August 29, 2016

Cancer diagnostics: the journey from histomorphology to molecular profiling August 19, 2016

Utilization of Sunitinib for Renal Cell Cancer: an Egyptian University hospital experience August 15, 2016

Page 279 of 456